CAS 36798-79-5: Budralazine
Formula:C14H16N4
InChI:InChI=1S/C14H16N4/c1-10(2)8-11(3)16-18-14-13-7-5-4-6-12(13)9-15-17-14/h4-9H,1-3H3,(H,17,18)
InChI key:InChIKey=DQGFCLJXYFXXIJ-UHFFFAOYSA-N
SMILES:N=1N=C(NN=C(C=C(C)C)C)C=2C=CC=CC2C1
- Synonyms:
- 1(2H)-Phthalazinone, (1,3-dimethyl-2-butenylidene)hydrazone
- 1-(2-(1,3-Dimethyl-2-Butenylidene)Hydrazino)Phthalazine
- 1-[(2E)-2-(1,3-dimethylbut-2-en-1-ylidene)hydrazino]phthalazine
- 1-[2-(1,3-Dimethyl-2-buten-1-ylidene)hydrazino]phthalazine
- 1-[2-(4-Methylpent-3-En-2-Ylidene)Hydrazinyl]Phthalazine
- 3-Penten-2-one, 4-methyl-, 2-(1-phthalazinyl)hydrazone
- Buterazine
- Dj 1461
- Budralazine
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Budralazine REF: TR-B689515CAS: 36798-79-5 | - - - | 352.00 €~2,322.00 € | Wed 07 May 25 |
![]() | Budralazine REF: TM-T23834CAS: 36798-79-5 | 98% | 908.00 €~2,375.00 € | Thu 15 May 25 |
![]() | Budralazine REF: 3D-LBA79879CAS: 36798-79-5 | Min. 95% | 95.00 €~759.00 € | Thu 22 May 25 |

Budralazine
Controlled ProductCAS:36798-79-5
Applications Budralazine a new antihypertensive agent. Budralazine is a direct-acting vasodilator. References Moroi, R. et …
Formula:
C14H16N4
Color and Shape:
Neat
Molecular weight:
240.30
Ref: TR-B689515
50mg | 352.00 € | ||
500mg | 2,322.00 € |
Estimated delivery in United States, on Wednesday 7 May 2025

Budralazine
CAS:36798-79-5
Budralazine is an agent of antihypertensive drug.
Formula:
C14H16N4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
240.3
Ref: TM-T23834
25mg | 1,444.00 € | ||
50mg | 1,882.00 € | ||
100mg | 2,375.00 € |
Estimated delivery in United States, on Thursday 15 May 2025

Budralazine
CAS:36798-79-5
Please enquire for more information about Budralazine including the price, delivery time and more detailed …
Formula:
C14H16N4
Purity:
Min. 95%
Molecular weight:
240.3 g/mol
Ref: 3D-LBA79879
2mg | 177.00 € | ||
5mg | 254.00 € | ||
10mg | 373.00 € | ||
25mg | 531.00 € | ||
50mg | 759.00 € |
Estimated delivery in United States, on Thursday 22 May 2025